RU2006138043A - Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации - Google Patents

Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации Download PDF

Info

Publication number
RU2006138043A
RU2006138043A RU2006138043/14A RU2006138043A RU2006138043A RU 2006138043 A RU2006138043 A RU 2006138043A RU 2006138043/14 A RU2006138043/14 A RU 2006138043/14A RU 2006138043 A RU2006138043 A RU 2006138043A RU 2006138043 A RU2006138043 A RU 2006138043A
Authority
RU
Russia
Prior art keywords
defibrinogenizing
agent
administered
defibrinogenization
stroke
Prior art date
Application number
RU2006138043/14A
Other languages
English (en)
Russian (ru)
Inventor
Стефен Дж. ПЕТТИ (US)
Стефен Дж. ПЕТТИ
Самн Раффаньелло ПЕТТИ (US)
Самн Раффаньелло ПЕТТИ
Original Assignee
Нойробайлоджикал Текнолоджиз, Инк. (Us)
Нойробайлоджикал Текнолоджиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нойробайлоджикал Текнолоджиз, Инк. (Us), Нойробайлоджикал Текнолоджиз, Инк. filed Critical Нойробайлоджикал Текнолоджиз, Инк. (Us)
Publication of RU2006138043A publication Critical patent/RU2006138043A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2006138043/14A 2004-03-30 2005-03-30 Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации RU2006138043A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/812,510 US20050220782A1 (en) 2004-03-30 2004-03-30 Method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern
US10/812,510 2004-03-30

Publications (1)

Publication Number Publication Date
RU2006138043A true RU2006138043A (ru) 2008-05-10

Family

ID=34964955

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006138043/14A RU2006138043A (ru) 2004-03-30 2005-03-30 Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации

Country Status (8)

Country Link
US (1) US20050220782A1 (https=)
EP (1) EP1740271A1 (https=)
JP (1) JP2007531759A (https=)
AU (1) AU2005231769A1 (https=)
CA (1) CA2561645A1 (https=)
IL (1) IL178426A0 (https=)
RU (1) RU2006138043A (https=)
WO (1) WO2005097262A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016110642A1 (de) * 2016-06-09 2017-12-14 Nordmark Holding Gmbh Verwendung von Ancrod zur Vorbeugung und/oder Behandlung von Ischämie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523292A (en) * 1992-10-14 1996-06-04 Schwartz; Robert Method of preventing restenosis following coronary angioplasty
US6165795A (en) * 1998-06-25 2000-12-26 Cardiovascular Diagnostics, Inc. Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles

Also Published As

Publication number Publication date
CA2561645A1 (en) 2005-10-20
AU2005231769A1 (en) 2005-10-20
IL178426A0 (en) 2007-02-11
JP2007531759A (ja) 2007-11-08
US20050220782A1 (en) 2005-10-06
WO2005097262A1 (en) 2005-10-20
EP1740271A1 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
CR6458A (es) Composiciones de valdecoxib
GB0410266D0 (en) Treatment of apoptosis
BR0212078A (pt) Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
WO2006130553A3 (en) Hcv protease inhibitors
RU2003131876A (ru) Композиции n-ацетилцистеина и способы лечения и профилактики токсичности лекарственных средств
BR0013540A (pt) Formulações farmacêuticas e seu uso na prevenção de acidente vascular cerebral, diabetes e/ou falha de coração congestiva
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
RU2010153688A (ru) Режим дозирования телапревира
CA2574450A1 (en) Method of treating hyperphosphataemia using lanthanum hydroxycarbonate
CO5251425A1 (es) Metodo y composiciones para administrar taxanos oralmente a pacientes humanos
WO2004010946A3 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
Tegner Severe skin pain after PUVA treatment
AR046410A1 (es) Composiciones farmaceuticas para la liberacion modificada de modafinilo
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
PT1656131E (pt) Utilização de betaína para tratar claudicação intermitente
RU2006113366A (ru) Терапевтическое лечение
RU2009101026A (ru) Применение тимозина-альфа-1 для получения лекарственного средства для лечения злокачественной меланомы на iv стадии
JPH01261334A (ja) アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法
RU2006138043A (ru) Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации
EA200800075A1 (ru) Схема дозирования для празугреля
WO2001080895A3 (en) Methods and compositions for the treatment of cardiac indications
EA200400348A1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
CA2368352A1 (en) Method for treating neurodegeneration
CA2469702A1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090618

FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090618